in Dr Armaghani's view, "practice-changing," and perhaps most importantly by the consolidation of a new clinical category, HER2-low, which represents a more nuanced picture in the treatment of metastatic breast
New Breast Cancer TreatmentProvides information on the MammoSite Radiation Therapy System for breast cancer.Medical Update
Breast Cancer Research and Treatment is a comprehensive forum dedicated to all aspects of breast cancer research. The journal's focus spans across various ...
WASHINGTON, Jan. 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) has expanded the approved use of a drug to treat certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation. It is the first time any drug has been approved to ...
2. Principles for disease assessment of advanced breast cancer 3. Principles for ABC treatment 4. Treatment of unresectable locally advanced breast cancer 5. General principles of chemotherapy for ABC 6. Treatment for HR+ and HER2- ABC 7. Treatment for HER2-positive ABC 8. Treatment for advanced...
《乳腺癌研究和治疗》(Breast Cancer Research And Treatment)是一本以医学-肿瘤学综合研究为特色的国际期刊。该刊由Springer US出版商创刊于1981年,刊期Semimonthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-肿瘤学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术...
William J. Gradishar, MD, provides an overview of the current breast cancer treatment landscape, highlights updates to the NCCN guidelines from 2023 to 2024, and expresses optimism for addressing unmet needs at ASCO 2024. This is a modal window. The Playback API request failed for an ...
SERDs are a new class of drugs that degrade estrogen receptors, thereby inhibiting the growth of hormone-dependent cancer cells. Drugs like Fulvestrant are being refined to improve their efficacy and oral availability, potentially offering more convenient treatment options. ...
The accumulating data represent the pledge of an expanded therapeutic space, Dr Armaghani implies, one in which agents formerly used against one cancer subtype may potentially extend to others, translating into an enriched array of options in the treatment of MBC....
Acharya-Leon: Looking at a clinical case, this is a patient with metastatic HER2-positive breast cancer who receives first-line therapy followed by maintenance therapy. She has episodes of headaches, and she has 3 new brain metastases [between] 4 to 6 mm. What [trea...